Drug profile · INN
becaplermin
GEMESIS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
becaplermin (GEMESIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN becaplermin
Brand GEMESIS
Route TOPICAL
Formulation GEL
ATC code D03AX06
Frequently asked questions
What is becaplermin?
becaplermin (GEMESIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for becaplermin?
GEMESIS is a marketed brand name for becaplermin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of becaplermin?
becaplermin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.